<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.sutrobio.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-21st-annual-future-leaders-in-the-biotech-industry-conference/</loc><lastmod>2022-05-24T15:53:08-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-collaborate-with-memorial-sloan-kettering-cancer-center-to-produce-bispecific-antibodies-for-the-treatment-of-neuroblastoma/</loc><lastmod>2022-05-24T15:53:42-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-closes-26-million-financing-expands-development-of-novel-immuno-oncology-products/</loc><lastmod>2022-05-24T15:54:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-dual-warhead-antibody-drug-conjugate-at-the-world-adc-summit/</loc><lastmod>2022-05-24T15:54:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-edward-c-albini-as-chief-financial-officer/</loc><lastmod>2022-05-24T15:57:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-collaborate-with-sanofi-pasteur-on-a-novel-production-approach-for-vaccine-candidates/</loc><lastmod>2022-05-24T15:57:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-collaborates-with-celgene-corporation-to-design-and-develop-next-generation-antibody-drug-conjugates-and-bispecific-antibodies/</loc><lastmod>2022-05-24T15:58:57-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-expands-senior-management-team-jeremy-bender-ph-d-joins-as-chief-business-officer-aaron-k-sato-ph-d-named-vice-president-research/</loc><lastmod>2022-05-24T15:59:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-closes-16-5-million-second-tranche-of-series-c-financing/</loc><lastmod>2022-05-24T15:59:53-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-announces-newly-formed-scientific-advisory-board-renowned-researchers-james-a-wells-ph-d-and-james-r-swartz-sc-d-to-guide-sutros-advancing-therapeutic-pipeline/</loc><lastmod>2022-05-24T16:00:57-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-its-biochemical-protein-synthesis-technology-at-bioproduction-conference-2011-in-berlin/</loc><lastmod>2022-05-24T16:03:41-07:00</lastmod></url><url><loc>https://www.sutrobio.com/study-shows-sutro-biopharmas-biochemical-protein-synthesis-technology-enables-rapid-production-and-scale-up-of-biopharmaceuticals-results-published-in-biotechnology-and-bioengineering-demonstrate-th/</loc><lastmod>2022-05-24T16:04:13-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-forges-partnership-with-pfizer-for-discovery-development-and-commercialization-of-novel-peptide-based-therapeutics-companys-first-major-collaboration-validates-potential-of-biochem/</loc><lastmod>2022-05-24T16:06:21-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-trevor-hallam-ph-d-as-chief-scientific-officer-appointment-reflects-biopharmaceutical-companys-commitment-to-the-development-of-novel-and-biosuperior-protein-therapeutics/</loc><lastmod>2022-05-24T16:06:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-secures-36-5-million-in-series-c-financing/</loc><lastmod>2022-05-24T16:07:54-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-additions-to-board-of-directors-and-senior-management-team/</loc><lastmod>2022-05-24T15:49:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-adds-to-extensive-ip-portfolio-with-two-newly-issued-patents-and-two-patent-grant-notices-covers-the-only-cell-free-synthesis-platform-applicable-to-protein-discovery-through-produc/</loc><lastmod>2022-05-24T15:46:20-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-hits-major-technical-milestone-reaching-100-liter-scale-for-the-companys-open-cell-free-protein-synthesis-technology-milestone-triggers-15-million-series-b-financing/</loc><lastmod>2022-05-24T15:45:58-07:00</lastmod></url><url><loc>https://www.sutrobio.com/william-j-newell-named-chief-executive-officer-of-sutro-biopharma-former-ceo-daniel-s-gold-ph-d-becomes-president-and-chief-operating-officer-company-notes-name-change-from-fundamental-applied/</loc><lastmod>2022-05-24T15:45:01-07:00</lastmod></url><url><loc>https://www.sutrobio.com/aglycosylated-antibodies-and-antibody-fragments-produced-in-a-scalable-in-vitro-transcription-translation-system/</loc><lastmod>2022-05-24T16:00:17-07:00</lastmod></url><url><loc>https://www.sutrobio.com/microscale-to-manufacturing-scale-up-of-cell-free-cytokine-production-a-new-approach-for-shortening-protein-production-development-timelines/</loc><lastmod>2022-05-24T16:04:42-07:00</lastmod></url><url><loc>https://www.sutrobio.com/producing-homogeneous-adcs-with-combination-warheads/</loc><lastmod>2022-05-24T15:55:20-07:00</lastmod></url><url><loc>https://www.sutrobio.com/rapid-design-and-manufacture-of-single-species-site-specific-adcs-using-cell-free-synthesis-with-nnaas/</loc><lastmod>2022-05-24T16:08:25-07:00</lastmod></url><url><loc>https://www.sutrobio.com/a-robust-rapid-and-scalable-cell-free-expression-system-for-the-production-and-engineering-of-fab-antibodies/</loc><lastmod>2022-05-24T16:07:28-07:00</lastmod></url><url><loc>https://www.sutrobio.com/translation-fidelity-rate-determination-in-a-cell-free-protein-synthesis-system-using-lc-ms/</loc><lastmod>2022-05-24T15:51:24-07:00</lastmod></url><url><loc>https://www.sutrobio.com/towards-scalable-cell-free-synthesis-of-non-native-amino-acid-containing-proteins/</loc><lastmod>2022-05-24T15:50:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/antibody-drug-conjugates-and-cancer-treatment-making-smart-bombs-smarter/</loc><lastmod>2022-05-24T15:55:59-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharmas-trevor-hallam-offers-a-glimpse-into-the-future-of-drug-design/</loc><lastmod>2022-05-24T16:01:32-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharmas-trevor-hallam-describes-a-future-cgmp-manufacturing-facility/</loc><lastmod>2022-05-24T16:01:58-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-cell-free-protein-expression-systems/</loc><lastmod>2022-05-24T16:02:40-07:00</lastmod></url><url><loc>https://www.sutrobio.com/industrializing-design-development-and-manufacturing-of-therapeutic-proteins/</loc><lastmod>2022-05-24T16:05:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/unnatural-selection/</loc><lastmod>2022-05-24T16:05:53-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-promising-protein-synthesis-technology/</loc><lastmod>2022-05-24T15:47:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/enwave-signs-commercial-license-with-sutro-biopharma-for-powderrev-technology/</loc><lastmod>2022-05-24T15:52:34-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharmas-xpress-cf-technology-nominated-for-best-scientific-innovation-by-world-adc/</loc><lastmod>2022-05-24T15:51:56-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-collaborate-with-university-of-california-san-francisco-ucsf-a-recombinant-antibody-network-ran-member/</loc><lastmod>2022-05-24T16:23:12-07:00</lastmod></url><url><loc>https://www.sutrobio.com/merck/</loc><lastmod>2022-05-24T16:22:48-07:00</lastmod></url><url><loc>https://www.sutrobio.com/fiercebiotech-names-sutro-biopharma-as-one-of-its-fierce-15-biotech-companies-of-2014/</loc><lastmod>2022-05-24T16:21:57-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-celgene-corporation-enter-multi-year-strategic-collaboration-and-option-to-acquire-agreement/</loc><lastmod>2022-05-24T16:21:30-07:00</lastmod></url><url><loc>https://www.sutrobio.com/cell-free-translation-of-peptides-and-proteins-from-high-throughput-screening-to-clinical-production/</loc><lastmod>2022-05-24T15:56:34-07:00</lastmod></url><url><loc>https://www.sutrobio.com/a-general-sequence-processing-and-analysis-program-for-protein-engineering/</loc><lastmod>2022-05-24T16:22:19-07:00</lastmod></url><url><loc>https://www.sutrobio.com/methods-to-make-homogenous-antibody-drug-conjugates/</loc><lastmod>2022-05-24T16:21:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/production-of-bispecific-antibodies-in-knobs-into-holes-using-a-cell-free-expression-system/</loc><lastmod>2022-05-24T16:20:45-07:00</lastmod></url><url><loc>https://www.sutrobio.com/preparation-and-testing-of-e-coli-s30-in-vitro-transcription-translation-extracts/</loc><lastmod>2022-05-24T16:03:14-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutrovax-raises-22-million-in-series-a/</loc><lastmod>2022-05-24T16:20:15-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-nicki-vasquez-ph-d-as-vp-of-alliance-and-project-management/</loc><lastmod>2022-05-24T16:19:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-receives-the-pantheon-2015-dina-outstanding-partner-award-by-the-california-life-sciences-association/</loc><lastmod>2022-05-24T16:19:19-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-expands-senior-leadership-team-with-addition-of-chief-medical-officer-and-vp-of-translational-pharmacology-and-preclinical-development/</loc><lastmod>2022-05-24T16:18:53-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-appoints-shabbir-t-anik-chief-technical-operations-officer/</loc><lastmod>2022-05-24T16:18:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-marks-important-progress-receives-two-milestone-payments-from-celgene/</loc><lastmod>2022-05-24T16:18:01-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-adcs-targeting-cd74-suppress-tumors-in-multiple-malignant-cell-lines-and-animal-models-of-multiple-myeloma-and-non-hodgkin-lymphoma/</loc><lastmod>2022-05-24T16:17:33-07:00</lastmod></url><url><loc>https://www.sutrobio.com/biotech-nation-radio-with-ceo-bill-newell/</loc><lastmod>2022-05-24T16:17:09-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-adc-targeting-cd74-exhibits-potent-anti-tumor-activity-in-multiple-malignant-cell-lines-and-animal-models-of-non-hodgkin-lymphoma-and-multiple-myeloma/</loc><lastmod>2022-05-24T16:15:55-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutrovax-announces-closing-of-64m-via-series-b-financing/</loc><lastmod>2022-05-24T16:15:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-adc-targeting-cd74-eradicates-b-cell-hematologic-malignancy-prolongs-survival-in-tumor-models/</loc><lastmod>2022-05-24T16:14:56-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-appoints-lobacki-as-director-leonard-krishnan-levy-as-advisors/</loc><lastmod>2022-05-24T16:13:58-07:00</lastmod></url><url><loc>https://www.sutrobio.com/biotechnology-saving-lives-transforming-healthcare-in-the-21st-century/</loc><lastmod>2022-05-24T16:13:18-07:00</lastmod></url><url><loc>https://www.sutrobio.com/cancers-next-gen-smart-bomb-who-will-be-first-to-weaponize-invivo/</loc><lastmod>2022-05-24T16:12:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/new-evidence-of-sutro-adcs-potency-in-human-tumor-xenografts/</loc><lastmod>2022-05-24T16:12:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/dr-moncef-slaoui-former-glaxosmithkline-chairman-of-vaccines-appointed-to-sutrovax-board-of-directors/</loc><lastmod>2022-05-24T16:11:49-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-celgene-to-refocus-2014-immuno-oncology-collaboration-on-four-programs/</loc><lastmod>2022-05-24T16:11:24-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-marks-two-drug-development-milestones/</loc><lastmod>2022-05-24T16:10:43-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-antibody-effectively-targets-cd74-in-lymphoma-multiple-myeloma-preclinical-studies/</loc><lastmod>2022-05-24T16:09:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-adc-effectively-targets-folate-receptor-alpha-in-ovarian-cancer-preclinical-research/</loc><lastmod>2022-05-24T16:31:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-initiates-first-clinical-trial-of-cd74-targeting-adc-for-lymphoma-the-first-of-a-new-generation-of-precisely-engineered-adcs/</loc><lastmod>2020-03-26T12:12:35-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-ceo-bill-newell-appointed-chair-of-the-california-life-sciences-association/</loc><lastmod>2022-05-24T16:30:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutrovax-announces-85m-series-c-financing-led-by-tpg-growth/</loc><lastmod>2022-05-24T16:29:35-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-collaborates-with-merck-to-develop-therapeutics-for-cancer-and-autoimmune-disorders/</loc><lastmod>2020-03-13T20:59:27-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-85-4-million-series-e-round/</loc><lastmod>2022-05-24T16:29:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-and-the-leukemia-lymphoma-society-partner-on-lymphoma-and-multiple-myeloma-treatment/</loc><lastmod>2020-03-26T12:08:37-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-taps-worsley-as-chief-business-officer-names-fitzpatrick-as-people-and-communications-chief/</loc><lastmod>2022-05-24T16:28:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-85-0-million-initial-public-offering/</loc><lastmod>2022-05-24T16:27:36-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutros-stro-001-receives-u-s-fda-orphan-drug-designation-for-treatment-of-multiple-myeloma/</loc><lastmod>2020-03-26T12:05:49-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-appoints-industry-veteran-shalini-sharp-to-board-of-directors/</loc><lastmod>2022-05-24T16:27:13-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-announces-ind-submission-and-conclusion-of-30-day-review-period-for-stro-002-an-antibody-drug-conjugate-adc-targeting-anti-folate-receptor-%ce%b1-for-treatment-of-ovarian-and-endometrial-canc/</loc><lastmod>2020-03-26T12:04:18-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-third-quarter-2018-financial-results/</loc><lastmod>2022-05-24T16:26:53-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-to-participate-in-the-30th-annual-piper-jaffray-healthcare-conference/</loc><lastmod>2022-05-24T16:26:25-07:00</lastmod></url><url><loc>https://www.sutrobio.com/stro-001-publication-highlights/</loc><lastmod>2022-05-24T16:32:57-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-achieves-10-million-milestone-payment-from-celgene/</loc><lastmod>2020-03-26T12:01:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-to-present-at-37th-annual-j-p-morgan-healthcare-conference/</loc><lastmod>2022-05-24T16:25:39-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-expands-leadership-team-with-appointment-of-vice-president-of-chemistry/</loc><lastmod>2022-05-24T16:25:12-07:00</lastmod></url><url><loc>https://www.sutrobio.com/non-confidential-corporate-presentation-jpm-2019/</loc><lastmod>2022-05-24T16:26:02-07:00</lastmod></url><url><loc>https://www.sutrobio.com/science-and-platform-publication-highlights/</loc><lastmod>2022-05-24T16:33:22-07:00</lastmod></url><url><loc>https://www.sutrobio.com/aacr-rivkin-abstract/</loc><lastmod>2022-05-24T16:27:59-07:00</lastmod></url><url><loc>https://www.sutrobio.com/stro-002-abstract-sgo-2018/</loc><lastmod>2022-05-24T16:32:18-07:00</lastmod></url><url><loc>https://www.sutrobio.com/stro-002-abstract-aacr-2018/</loc><lastmod>2022-05-24T16:31:46-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sgo-stro-002-poster/</loc><lastmod>2022-05-24T16:32:38-07:00</lastmod></url><url><loc>https://www.sutrobio.com/2016-american-society-of-hematology-nhl-oral-presentation/</loc><lastmod>2022-05-24T16:16:20-07:00</lastmod></url><url><loc>https://www.sutrobio.com/stro-002-aacr-2018-poster/</loc><lastmod>2022-05-24T16:30:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/stro-002-rivkin-poster/</loc><lastmod>2022-05-24T16:28:48-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-clinical-oncology-2018-poster/</loc><lastmod>2022-05-24T16:30:04-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-2017-poster/</loc><lastmod>2022-05-24T16:14:31-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-hematology-ash-2017-oral-presentation/</loc><lastmod>2022-05-24T16:10:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-hematology-ash-2016-poster/</loc><lastmod>2022-05-24T16:16:45-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-cowen-and-company-39th-annual-health-care-conference/</loc><lastmod>2022-05-24T16:24:49-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-initiates-phase-i-clinical-trial-of-stro-002-for-the-treatment-of-ovarian-and-endometrial-cancers/</loc><lastmod>2022-05-24T16:24:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-full-year-2018-financial-results-and-recent-business-highlights-and-developments/</loc><lastmod>2022-05-24T16:24:04-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-18th-annual-needham-healthcare-conference/</loc><lastmod>2022-05-24T16:44:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-2019-stro-001-poster/</loc><lastmod>2022-05-24T16:44:28-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-2019-stro-002-poster/</loc><lastmod>2022-05-24T16:44:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-2019-stro-002-abstract-3897/</loc><lastmod>2022-05-24T16:43:45-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-first-quarter-2019-financial-results-and-recent-business-highlights-and-developments/</loc><lastmod>2022-05-24T16:43:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-presentation-at-the-2019-european-hematology-association-congress/</loc><lastmod>2022-05-24T16:43:02-07:00</lastmod></url><url><loc>https://www.sutrobio.com/european-hematology-association-eha-2019-stro-001-abstract/</loc><lastmod>2022-05-24T16:42:39-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-encouraging-interim-phase-1-safety-data-on-a-potential-first-in-class-antibody-drug-conjugate-stro-001-for-the-treatment-of-b-cell-malignancies-at-the-european-hematology-ass/</loc><lastmod>2022-05-24T16:42:14-07:00</lastmod></url><url><loc>https://www.sutrobio.com/european-hematology-association-congress-eha-2019-stro-001-poster/</loc><lastmod>2022-05-24T16:41:46-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-jmp-securities-life-sciences-conference/</loc><lastmod>2022-05-24T16:41:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-biopharma-veteran-connie-matsui-as-board-chair/</loc><lastmod>2022-05-24T16:41:00-07:00</lastmod></url><url><loc>https://www.sutrobio.com/international-conference-in-malignant-lymphoma-icml-2019-stro-001-poster/</loc><lastmod>2022-05-24T16:40:32-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-2019-wedbush-pacgrow-healthcare-conference/</loc><lastmod>2022-05-24T16:40:05-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-second-quarter-2019-financial-results-and-recent-business-highlights-and-developments/</loc><lastmod>2022-05-24T16:39:39-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-h-c-wainwright-21st-annual-healthcare-conference/</loc><lastmod>2022-05-24T16:39:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-receive-milestone-payment-for-novel-bispecific-antibody-drug-conjugate-targeting-solid-tumors/</loc><lastmod>2020-03-26T05:03:39-07:00</lastmod></url><url><loc>https://www.sutrobio.com/world-anti-body-drug-conjugate-adc-2019-process-development-and-scale-up-for-site-specific-bioconjugate-conjugation-and-purification-poster/</loc><lastmod>2022-05-24T16:38:48-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-presentation-of-stro-002-for-the-potential-treatment-of-ovarian-and-endometrial-cancer-at-the-2019-aacr-nci-eortc-molecular-targets-and-cancer-therapeutics-conference/</loc><lastmod>2022-05-24T16:38:21-07:00</lastmod></url><url><loc>https://www.sutrobio.com/aacr-nci-eortc-molecular-targets-and-cancer-therapeutics-conference-2019-stro-002-abstract/</loc><lastmod>2022-05-24T16:37:52-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-2019-aacr-nci-eortc-molecular-targets-and-cancer-therapeutics-conference/</loc><lastmod>2022-05-24T16:37:29-07:00</lastmod></url><url><loc>https://www.sutrobio.com/aacr-nci-eortc-molecular-targets-and-cancer-therapeutics-conference-2019-poster/</loc><lastmod>2022-05-24T16:37:04-07:00</lastmod></url><url><loc>https://www.sutrobio.com/aacr-nci-eortc-molecular-targets-and-cancer-therapeutics-conference-2019-powerpoint-presentation/</loc><lastmod>2022-05-24T16:36:40-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-hematology-conference-2019-stro-001-abstract/</loc><lastmod>2022-05-24T16:36:18-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-third-quarter-2019-financial-results-and-recent-business-highlights-and-developments/</loc><lastmod>2022-05-24T16:35:51-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-stifel-2019-healthcare-conference/</loc><lastmod>2022-05-24T16:35:33-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutros-ceo-bill-newell-was-live-today-on-td-ameritrade/</loc><lastmod>2022-05-24T16:35:10-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-the-31st-annual-piper-jaffray-healthcare-conference/</loc><lastmod>2022-05-24T16:34:52-07:00</lastmod></url><url><loc>https://www.sutrobio.com/cell-free-systems-conference-2019-antibody-reduction-mitigation-during-harvest-from-cell-free-protein-synthesis-poster/</loc><lastmod>2022-05-24T16:34:32-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-extension-of-first-cytokine-derivative-research-program-under-collaboration-with-merck/</loc><lastmod>2020-03-31T08:36:59-07:00</lastmod></url><url><loc>https://www.sutrobio.com/10th-annual-world-adc-london-2020-powerpoint-presentation/</loc><lastmod>2022-05-24T16:52:52-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-innovative-cancer-therapy-approach-using-precise-tumor-targeted-immunostimulants-at-world-adc-london/</loc><lastmod>2022-05-24T16:53:17-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-cowen-and-company-40th-annual-health-care-conference/</loc><lastmod>2022-05-24T16:53:31-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-expands-senior-management-team-with-the-appointments-of-vice-president-of-immunobiology-and-vice-president-of-business-development/</loc><lastmod>2022-05-24T16:53:49-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-38th-annual-j-p-morgan-healthcare-conference/</loc><lastmod>2022-05-24T16:54:02-07:00</lastmod></url><url><loc>https://www.sutrobio.com/open-letter-from-our-ceo/</loc><lastmod>2020-05-11T12:14:59-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-james-panek-to-board-of-directors/</loc><lastmod>2022-05-24T16:33:55-07:00</lastmod></url><url><loc>https://www.sutrobio.com/cell-free-systems-conference-2019-cell-free-protein-synthesis-scale-up-and-gmp-production-of-protein-biotherapeutics-for-clinical-trials-poster/</loc><lastmod>2022-05-24T16:34:13-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-full-year-2019-financial-results-and-recent-business-highlights-and-developments/</loc><lastmod>2022-05-24T16:52:24-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutrovax-announces-110m-series-d-financing-to-advance-broadest-spectrum-pneumococcal-vaccine-candidates-to-prevent-pneumonia/</loc><lastmod>2022-05-24T16:51:58-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-virtual-annual-meeting-2020-stro-002-abstract/</loc><lastmod>2022-05-24T16:50:34-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-updated-clinical-data-for-its-stro-002-antibody-drug-conjugate-at-the-aacr-virtual-annual-meeting-on-april-27-2020/</loc><lastmod>2022-05-24T16:51:40-07:00</lastmod></url><url><loc>https://www.sutrobio.com/dr-wendel-naumann-of-the-levine-cancer-institute-virtual-presentation-of-stro-002-antibody-drug-conjugate-adc-at-the-american-association-for-cancer-research-aacr-virtual-annual-meeting-2020/</loc><lastmod>2022-05-24T16:50:17-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-host-conference-call-on-april-27-2020-to-provide-clinical-update-on-its-stro-002-antibody-drug-conjugate/</loc><lastmod>2022-05-24T16:51:20-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-encouraging-interim-phase-1-clinical-data-for-a-dose-escalation-study-of-stro-002-antibody-drug-conjugate-in-ovarian-cancer/</loc><lastmod>2020-05-11T11:43:36-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-host-analyst-and-investor-conference-call-april-27-2020-powerpoint-presentation/</loc><lastmod>2022-05-24T16:50:54-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-proposed-public-offering/</loc><lastmod>2022-05-24T16:50:01-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-first-quarter-2020-financial-results-and-recent-business-highlights-and-developments/</loc><lastmod>2022-05-24T16:49:43-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-pricing-of-85-3-million-public-offering/</loc><lastmod>2022-05-24T16:49:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-closing-of-98-0-million-public-offering-including-full-exercise-of-the-underwriters-option-to-purchase-additional-shares/</loc><lastmod>2022-05-24T16:49:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-expands-senior-management-with-the-additions-of-vice-president-of-clinical-development-and-vice-president-of-finance-and-controller/</loc><lastmod>2022-05-24T16:48:36-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-adds-two-exceptional-leaders-to-advisory-boards-carlos-paya-md-phd-and-lainie-martin-md/</loc><lastmod>2022-05-24T16:48:52-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutrovax-announces-name-change-to-vaxcyte/</loc><lastmod>2022-05-24T16:48:21-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-new-preclinical-data-on-its-stro-002-antibody-drug-conjugate-at-the-upcoming-aacr-2020-virtual-meeting-on-june-22-2020/</loc><lastmod>2022-05-24T16:48:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-new-preclinical-data-at-2020-aacr-virtual-annual-meeting-ii-suggesting-synergy-between-its-stro-002-antibody-drug-conjugate-and-immune-checkpoint-inhibitors-resulting-in-tumor/</loc><lastmod>2022-05-24T16:47:30-07:00</lastmod></url><url><loc>https://www.sutrobio.com/m1231-a-first-in-class-bispecific-adc-targeting-egfr-and-muc1-presented-by-emd-serono-at-american-association-for-cancer-research-aacr-virtual-meeting-ii-on-june-24-2020-presentation/</loc><lastmod>2022-05-24T16:46:35-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-2020-virtual-meeting-ii-poster/</loc><lastmod>2022-05-24T16:47:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-2020-virtual-meeting-ii-abstract/</loc><lastmod>2022-05-24T16:46:52-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-2020-virtual-meeting-ii-poster-script/</loc><lastmod>2022-05-24T16:47:49-07:00</lastmod></url><url><loc>https://www.sutrobio.com/bristol-myers-squibb-investor-series/</loc><lastmod>2022-05-24T16:46:16-07:00</lastmod></url><url><loc>https://www.sutrobio.com/open-letter-from-our-ceo-2/</loc><lastmod>2022-05-24T16:45:30-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-second-quarter-2020-financial-results-and-provides-business-highlights-and-developments/</loc><lastmod>2022-05-24T17:02:35-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-2020-wedbush-pacgrow-healthcare-virtual-conference/</loc><lastmod>2022-05-24T17:02:20-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-two-executive-promotions-to-vice-president-of-quality-and-vice-president-of-manufacturing/</loc><lastmod>2022-05-24T17:02:01-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-earns-clinical-supply-milestone-payment-from-merck-kgaa-darmstadt-germany-for-novel-bispecific-antibody-drug-conjugate-targeting-solid-tumors/</loc><lastmod>2020-08-25T04:01:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/igcs-2020-annual-global-meeting-abstract/</loc><lastmod>2022-05-24T17:01:43-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-promising-stro-002-interim-phase-1-clinical-data-in-ovarian-cancer-and-presentation-at-the-2020-igcs-annual-global-meeting/</loc><lastmod>2022-05-24T17:01:27-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-two-upcoming-investor-conferences/</loc><lastmod>2022-05-24T17:01:12-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-promising-stro-002-interim-phase-1-clinical-data-in-ovarian-cancer-at-the-2020-igcs-annual-global-meeting/</loc><lastmod>2022-05-24T17:00:51-07:00</lastmod></url><url><loc>https://www.sutrobio.com/international-gynecologic-cancer-society-igcs-virtual-healthcare-conference-2020-poster/</loc><lastmod>2022-05-24T17:00:19-07:00</lastmod></url><url><loc>https://www.sutrobio.com/investor-conference-call-september-9-2020-presentation/</loc><lastmod>2022-05-24T17:00:35-07:00</lastmod></url><url><loc>https://www.sutrobio.com/stro-002-shows-early-efficacy-safety-in-heavily-pretreated-epithelial-ovarian-cancer-onclive-september-2020/</loc><lastmod>2022-05-24T16:59:54-07:00</lastmod></url><url><loc>https://www.sutrobio.com/cantor-fitzgerald-virtual-heathcare-conference-2020-powerpoint-presentation/</loc><lastmod>2022-05-24T16:59:37-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-at-world-adc-2020-powerpoint-presentation/</loc><lastmod>2022-05-24T16:59:24-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-named-best-new-drug-developer-at-the-7th-annual-world-adc/</loc><lastmod>2022-05-24T16:59:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-hematology-conference-2020-stro-001-abstract/</loc><lastmod>2022-05-24T16:58:48-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-third-quarter-2020-financial-results-and-provides-business-highlights-and-developments/</loc><lastmod>2022-05-24T16:58:30-07:00</lastmod></url><url><loc>https://www.sutrobio.com/adc-review-oncozine/</loc><lastmod>2022-05-24T16:58:12-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-four-upcoming-investor-conferences/</loc><lastmod>2022-05-24T16:57:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-hematology-ash-2020-presentation/</loc><lastmod>2022-05-24T16:55:14-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-the-appointment-of-diana-landa-as-vice-president-of-regulatory-affairs-and-annie-chang-as-head-of-investor-relations/</loc><lastmod>2022-05-24T16:57:31-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-host-a-virtual-kol-event-to-provide-clinical-update-on-antibody-drug-conjugate-stro-002-in-ovarian-cancer/</loc><lastmod>2022-05-24T16:57:08-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-appointment-of-jon-m-wigginton-m-d-to-board-of-directors/</loc><lastmod>2022-05-24T16:56:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-encouraging-interim-data-on-stro-002-phase-1-dose-escalation-study-for-patients-with-ovarian-cancer/</loc><lastmod>2022-05-24T16:56:32-07:00</lastmod></url><url><loc>https://www.sutrobio.com/kol-discussion-of-stro-002-data-powerpoint-presentation/</loc><lastmod>2022-05-24T16:56:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/bill-newell-ceo-interviewed-by-moira-gunn-on-technation-radio-podcast-episode-20-40-the-pivot-from-hep-b-to-covid-19/</loc><lastmod>2022-05-24T16:55:53-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-data-from-ongoing-phase-1-dose-escalation-study-for-stro-001-for-the-treatment-of-b-cell-non-hodgkin-lymphoma-at-the-62nd-american-society-of-hematology-annual-meeting/</loc><lastmod>2022-05-24T16:55:31-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-proposed-public-offering-of-5-million-shares-of-common-stock/</loc><lastmod>2022-05-24T16:54:55-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-pricing-of-126-0-million-public-offering/</loc><lastmod>2022-05-24T16:54:38-07:00</lastmod></url><url><loc>https://www.sutrobio.com/oncozine-ash-2020-preclinical-models-identify-cd74-as-potential-target-for-the-treatment-of-aml/</loc><lastmod>2022-05-24T16:54:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-closing-of-upsized-144-9-million-public-offering-including-full-exercise-of-the-underwriters-option-to-purchase-additional-shares/</loc><lastmod>2022-05-24T15:43:17-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-39th-annual-j-p-morgan-virtual-healthcare-conference/</loc><lastmod>2021-01-05T04:00:51-08:00</lastmod></url><url><loc>https://www.sutrobio.com/biospace-sutro-maximizes-synergy-to-treat-cancer-and-preserve-quality-of-life/</loc><lastmod>2021-02-23T04:13:16-08:00</lastmod></url><url><loc>https://www.sutrobio.com/39th-annual-jp-morgan-healthcare-conference-presentation/</loc><lastmod>2022-05-24T17:04:22-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-first-patient-dosed-in-the-dose-expansion-study-of-stro-002-in-patients-with-ovarian-cancer/</loc><lastmod>2021-01-21T11:04:58-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-the-cowen-41st-annual-healthcare-conference/</loc><lastmod>2022-05-24T17:04:30-07:00</lastmod></url><url><loc>https://www.sutrobio.com/bill-newell-ceo-interviewed-by-biotech-2050/</loc><lastmod>2021-02-24T05:10:15-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-at-the-11th-annual-world-adc-europe-2021-powerpoint-presentation/</loc><lastmod>2022-05-24T17:04:38-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-full-year-2020-financial-results-and-provides-business-highlights-and-2021-anticipated-milestones/</loc><lastmod>2021-03-18T04:00:37-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-strengthens-leadership-through-management-promotions-and-expansion-of-clinical-advisory-board/</loc><lastmod>2021-03-22T04:01:40-07:00</lastmod></url><url><loc>https://www.sutrobio.com/open-letter-from-ceo-bill-newell/</loc><lastmod>2021-04-01T06:46:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-two-upcoming-investor-conferences-2/</loc><lastmod>2022-05-24T17:04:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-earns-milestone-payment-from-cytokine-derivatives-collaboration-with-merck/</loc><lastmod>2021-04-15T04:11:28-07:00</lastmod></url><url><loc>https://www.sutrobio.com/20th-annual-needham-virtual-healthcare-conference-presentation/</loc><lastmod>2022-05-24T17:05:10-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-promotes-trevor-hallam-ph-d-to-president-of-research-and-chief-scientific-officer/</loc><lastmod>2021-04-20T04:00:17-07:00</lastmod></url><url><loc>https://www.sutrobio.com/7th-annual-truist-securities-life-sciences-summit-presentation/</loc><lastmod>2021-05-04T10:53:59-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-first-quarter-2021-financial-results-business-highlights-and-2021-anticipated-milestones/</loc><lastmod>2021-05-14T04:23:04-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-upcoming-virtual-investor-conferences/</loc><lastmod>2022-05-24T17:04:56-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-clinical-oncology-asco-virtual-annual-meeting-2021-stro-002-abstract/</loc><lastmod>2021-05-19T14:01:35-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-additional-data-for-dose-escalation-phase-1-study-of-stro-002-to-be-presented-at-asco-2021/</loc><lastmod>2021-05-19T14:01:14-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-earns-milestone-payment-from-bispecific-antibody-drug-conjugate-collaboration-with-merck-kgaa-darmstadt-germany/</loc><lastmod>2021-06-01T04:00:41-07:00</lastmod></url><url><loc>https://www.sutrobio.com/jefferies-virtual-healthcare-conference-2021-presentation/</loc><lastmod>2021-11-15T04:19:25-08:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-clinical-oncology-asco-virtual-annual-meeting-2021-presentation/</loc><lastmod>2021-06-08T19:36:19-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-society-of-clinical-oncology-asco-virtual-annual-meeting-2021-poster/</loc><lastmod>2021-06-08T19:41:53-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-two-virtual-investor-conferences-in-june/</loc><lastmod>2021-06-15T04:11:24-07:00</lastmod></url><url><loc>https://www.sutrobio.com/bill-newell-ceo-interviewed-by-peter-holland-of-the-oncozine-brief-antibody-drug-conjugates-coming-of-age/</loc><lastmod>2022-06-02T12:47:00-07:00</lastmod></url><url><loc>https://www.sutrobio.com/nicki-vasquez-svp-alliance-management-portfolio-strategy-and-operations-interviewed-by-elaine-quilici-of-pharmaceutical-executive-firsthand-views-latinos-in-pharma/</loc><lastmod>2021-07-09T11:02:59-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference/</loc><lastmod>2021-07-29T04:00:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-jane-chung-as-chief-commercial-officer/</loc><lastmod>2021-08-09T04:00:21-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-second-quarter-2021-financial-results-business-highlights-and-anticipated-second-half-2021-milestones/</loc><lastmod>2021-11-09T18:51:58-08:00</lastmod></url><url><loc>https://www.sutrobio.com/12th-annual-wedbush-pacgrow-healthcare-virtual-conference-2021-presentation/</loc><lastmod>2021-11-15T04:15:46-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-stro-002-fda-fast-track-designation-for-patients-with-advanced-ovarian-cancer/</loc><lastmod>2021-08-18T04:00:41-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-the-2021-wells-fargo-virtual-healthcare-conference/</loc><lastmod>2021-09-01T04:00:32-07:00</lastmod></url><url><loc>https://www.sutrobio.com/2021-wells-fargo-virtual-healthcare-conference-presentation/</loc><lastmod>2021-11-15T04:11:58-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-expansion-of-leadership-team/</loc><lastmod>2021-09-16T04:14:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/</loc><lastmod>2021-09-17T14:04:56-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-extension-of-cytokine-derivative-research-program-under-collaboration-with-merck/</loc><lastmod>2021-09-30T04:00:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-bionova-pharmaceuticals-enter-into-collaboration-for-stro-001-in-greater-china/</loc><lastmod>2021-10-12T09:04:37-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-three-upcoming-investor-conferences/</loc><lastmod>2021-11-09T18:03:05-08:00</lastmod></url><url><loc>https://www.sutrobio.com/senior-scientist-senior-engineer-downstream-process-development-south-san-francisco-ca/</loc><lastmod>2022-12-22T07:56:40-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-third-quarter-2021-financial-results-business-highlights-and-anticipated-2021-milestones/</loc><lastmod>2021-11-10T04:00:54-08:00</lastmod></url><url><loc>https://www.sutrobio.com/credit-suisse-30th-annual-healthcare-conference-presentation/</loc><lastmod>2021-11-15T04:08:49-08:00</lastmod></url><url><loc>https://www.sutrobio.com/stifel-2021-virtual-healthcare-conference-presentation/</loc><lastmod>2021-11-15T03:59:44-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-appointment-of-heidi-hunter-to-board-of-directors/</loc><lastmod>2021-11-17T04:00:56-08:00</lastmod></url><url><loc>https://www.sutrobio.com/jefferies-london-healthcare-conference-presentation/</loc><lastmod>2021-11-17T20:53:37-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-two-upcoming-investor-conferences/</loc><lastmod>2021-11-22T04:00:18-08:00</lastmod></url><url><loc>https://www.sutrobio.com/piper-sandler-33rd-annual-healthcare-conference-presentation/</loc><lastmod>2021-11-22T07:00:02-08:00</lastmod></url><url><loc>https://www.sutrobio.com/4th-annual-evercore-isi-heathconx-conference-presentation/</loc><lastmod>2021-12-20T09:21:54-08:00</lastmod></url><url><loc>https://www.sutrobio.com/40th-annual-j-p-morgan-heathcare-conference-presentation/</loc><lastmod>2022-01-10T04:04:53-08:00</lastmod></url><url><loc>https://www.sutrobio.com/fred-hutchinson-cancer-research-center-in-partnership-with-sutro-biopharma-to-present-at-ash-2021/</loc><lastmod>2021-12-13T04:00:18-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-tasly-biopharmaceuticals-enter-into-exclusive-license-agreement-for-stro-002-in-greater-china/</loc><lastmod>2021-12-27T04:00:34-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-company-kol-virtual-event-to-provide-interim-dose-expansion-data-for-antibody-drug-conjugate-program-stro-002-for-treatment-of-advanced-ovarian-cancer/</loc><lastmod>2021-12-27T04:00:54-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-40th-annual-j-p-morgan-virtual-healthcare-conference/</loc><lastmod>2022-01-06T04:00:08-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-interim-data-from-dose-expansion-cohort-of-stro-002-phase-1-study-for-patients-with-advanced-ovarian-cancer/</loc><lastmod>2022-01-08T10:24:21-08:00</lastmod></url><url><loc>https://www.sutrobio.com/2022-kol-discussion-of-stro-002-phase-1-interim-dose-expansion-data-presentation/</loc><lastmod>2022-01-10T03:33:44-08:00</lastmod></url><url><loc>https://www.sutrobio.com/63rd-american-society-of-hematology-ash-annual-meeting-and-exposition-non-audio-presentation/</loc><lastmod>2022-01-11T09:00:17-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2/</loc><lastmod>2022-05-08T07:31:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/21st-annual-needham-virtual-healthcare-conference-presentation/</loc><lastmod>2022-06-09T11:42:19-07:00</lastmod></url><url><loc>https://www.sutrobio.com/kristin-bedard-ph-d-vp-of-discovery-interviewed-by-gail-dutton-biospace-in-a-recent-article-sutro-delivers-evidence-of-one-two-immunogenic-punch-at-aacr/</loc><lastmod>2022-05-08T08:31:17-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-nonclinical-data-for-antibody-drug-conjugate-stro-002-at-the-aacr-annual-meeting-2022/</loc><lastmod>2022-05-08T08:44:48-07:00</lastmod></url><url><loc>https://www.sutrobio.com/american-association-for-cancer-research-aacr-annual-meeting-2022-presentation/</loc><lastmod>2022-05-08T16:41:49-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-21st-annual-needham-virtual-healthcare-conference/</loc><lastmod>2022-05-08T16:49:23-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presented-on-advances-in-novel-immunostimulatory-antibody-drug-conjugate-modality-at-the-12th-annual-world-adc/</loc><lastmod>2022-05-08T16:55:54-07:00</lastmod></url><url><loc>https://www.sutrobio.com/12th-annual-world-adc-london-2022-presentations/</loc><lastmod>2022-05-08T17:10:41-07:00</lastmod></url><url><loc>https://www.sutrobio.com/cowen-42nd-annual-healthcare-conference-presentation/</loc><lastmod>2022-05-08T17:20:34-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-the-cowen-42nd-annual-healthcare-conference/</loc><lastmod>2022-05-08T17:26:19-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-full-year-2021-financial-results-business-highlights-and-anticipated-2022-milestones/</loc><lastmod>2022-05-08T17:34:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-first-quarter-2022-financial-results-business-highlights-and-anticipated-milestones/</loc><lastmod>2022-06-02T03:53:55-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-upcoming-investor-conferences/</loc><lastmod>2022-06-02T04:00:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-participated-in-a-clinical-trial-egg-derived-anti-sars-cov-2-immunoglobulin-y-igy-with-broad-variant-activity-as-intranasal-prophylaxis-against-covid-19-published-by-frontiers-i/</loc><lastmod>2022-06-02T04:57:13-07:00</lastmod></url><url><loc>https://www.sutrobio.com/bill-newell-ceo-interviewed-by-dr-michelle-mcmurry-heath-on-i-am-bio-podcast-episode-73-investors-become-goldilocks-in-a-bear-market/</loc><lastmod>2022-06-02T13:23:17-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-3/</loc><lastmod>2022-06-03T13:11:16-07:00</lastmod></url><url><loc>https://www.sutrobio.com/2022-asco-annual-meeting-abstract/</loc><lastmod>2022-06-04T13:28:02-07:00</lastmod></url><url><loc>https://www.sutrobio.com/jefferies-healthcare-conference-2022-presentation/</loc><lastmod>2022-06-16T04:05:24-07:00</lastmod></url><url><loc>https://www.sutrobio.com/jmp-securities-life-sciences-conference-presentation/</loc><lastmod>2022-06-17T11:01:22-07:00</lastmod></url><url><loc>https://www.sutrobio.com/22nd-annual-federation-of-clinical-immunology-societies-focis-meeting-2022-abstract-and-poster-presentation/</loc><lastmod>2022-06-23T18:19:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/astellas-and-sutro-biopharma-announce-worldwide-strategic-collaboration-to-advance-novel-immunostimulatory-antibody-drug-conjugates-iadcs/</loc><lastmod>2022-10-24T03:53:54-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-virtual-deep-dive-research-forum-next-gen-innovations-in-adcs/</loc><lastmod>2022-07-12T04:00:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-virtual-deep-dive-research-forum-next-gen-innovations-in-adcs-presentation/</loc><lastmod>2022-07-20T15:10:57-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-achieves-first-in-human-milestone-in-cytokine-derivatives-collaboration-with-merck/</loc><lastmod>2022-07-26T13:01:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-2022-wedbush-pacgrow-healthcare-conference/</loc><lastmod>2022-08-03T04:00:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-second-quarter-2022-financial-results-business-highlights-and-anticipated-milestones/</loc><lastmod>2022-10-24T03:52:41-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-4/</loc><lastmod>2022-10-24T03:51:40-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-2022-wells-fargo-healthcare-conference/</loc><lastmod>2022-10-24T03:50:44-07:00</lastmod></url><url><loc>https://www.sutrobio.com/head-of-chemistry-south-san-francisco-ca/</loc><lastmod>2023-03-27T16:21:45-07:00</lastmod></url><url><loc>https://www.sutrobio.com/2022-wells-fargo-healthcare-conference-presentation/</loc><lastmod>2022-09-09T07:24:32-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-departure-of-chief-medical-officer/</loc><lastmod>2022-10-24T04:00:09-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-upcoming-investor-conferences-2/</loc><lastmod>2022-11-02T04:00:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-oral-presentation-at-the-64th-american-society-of-hematology-annual-meeting-and-exposition/</loc><lastmod>2022-11-03T06:00:05-07:00</lastmod></url><url><loc>https://www.sutrobio.com/64th-american-society-of-hematology-annual-meeting-and-exposition-abstract/</loc><lastmod>2022-11-03T06:44:55-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-third-quarter-2022-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2022-11-08T13:30:07-08:00</lastmod></url><url><loc>https://www.sutrobio.com/credit-suisse-31st-annual-healthcare-conference-presentation/</loc><lastmod>2022-11-09T03:57:05-08:00</lastmod></url><url><loc>https://www.sutrobio.com/37th-annual-meeting-society-for-immunotherapy-of-cancer-sitc-2022-abstracts/</loc><lastmod>2022-11-11T14:55:17-08:00</lastmod></url><url><loc>https://www.sutrobio.com/jefferies-london-healthcare-conference-presentation-2/</loc><lastmod>2022-11-29T16:30:28-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-upcoming-investor-conferences-3/</loc><lastmod>2022-11-23T04:00:06-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-presentation-of-stro-002-data-from-the-compassionate-use-program-in-pediatric-patients-with-relapsed-refractory-cbf-glis-aml-at-ash-2022/</loc><lastmod>2022-12-20T11:57:12-08:00</lastmod></url><url><loc>https://www.sutrobio.com/64th-american-society-of-hematology-annual-meeting-and-exposition-non-audio-presentation/</loc><lastmod>2022-12-10T09:15:02-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-vaxcyte-enter-into-option-grant-agreement-for-the-development-and-manufacturing-rights-of-cell-free-extract/</loc><lastmod>2022-12-20T13:05:06-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-provide-data-update-on-stro-002-and-plans-for-registrational-path-forward-in-advanced-ovarian-cancer/</loc><lastmod>2022-12-21T05:00:13-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference/</loc><lastmod>2023-01-04T05:00:12-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-update-from-stro-002-luveltamab-tazevibulin-luvelta-phase-1-dose-expansion-study-and-registrational-plans-in-advanced-ovarian-cancer/</loc><lastmod>2023-01-09T13:05:04-08:00</lastmod></url><url><loc>https://www.sutrobio.com/update-on-stro-002-program-and-plans-for-registrational-trial-in-advanced-ovarian-cancer-presentation/</loc><lastmod>2024-04-14T13:01:40-07:00</lastmod></url><url><loc>https://www.sutrobio.com/qc-data-reviewer-san-carlos-ca/</loc><lastmod>2023-01-10T09:29:50-08:00</lastmod></url><url><loc>https://www.sutrobio.com/41st-annual-jp-morgan-healthcare-conference-presentation/</loc><lastmod>2024-04-14T12:57:56-07:00</lastmod></url><url><loc>https://www.sutrobio.com/discovery-of-stro-002-a-novel-homogeneous-adc-targeting-folate-receptor-alpha-for-the-treatment-of-ovarian-and-endometrial-cancers-molecular-cancer-therapeutics-aacr-journals/</loc><lastmod>2023-02-07T15:26:19-08:00</lastmod></url><url><loc>https://www.sutrobio.com/bionova-announces-first-patient-dosed-in-a-phase-1-2-study-of-bn301-for-the-treatment-of-hematologic-malignancies-in-china/</loc><lastmod>2023-02-13T08:36:24-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-5/</loc><lastmod>2023-02-17T13:01:14-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-dr-anne-borgman-as-chief-medical-officer/</loc><lastmod>2023-02-28T05:02:25-08:00</lastmod></url><url><loc>https://www.sutrobio.com/associate-director-engineering-san-carlos-ca/</loc><lastmod>2023-02-28T11:46:01-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-cowen-43rd-annual-health-care-conference/</loc><lastmod>2023-03-01T05:00:05-08:00</lastmod></url><url><loc>https://www.sutrobio.com/13th-annual-world-adc-london-2023-presentation/</loc><lastmod>2024-04-14T12:56:45-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-6/</loc><lastmod>2023-03-17T13:01:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/global-clinical-trial-leader-south-san-francisco-ca/</loc><lastmod>2023-03-27T16:22:32-07:00</lastmod></url><url><loc>https://www.sutrobio.com/director-safety-assessment-south-san-francisco-ca/</loc><lastmod>2023-03-22T14:53:51-07:00</lastmod></url><url><loc>https://www.sutrobio.com/director-upstream-process-development-south-san-francisco-ca/</loc><lastmod>2023-03-24T13:47:27-07:00</lastmod></url><url><loc>https://www.sutrobio.com/executive-director-clinical-development-md-south-san-francisco-ca/</loc><lastmod>2023-03-27T16:23:38-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-full-year-2022-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2023-03-30T13:30:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/qc-contractor-san-carlos-ca/</loc><lastmod>2023-04-07T08:03:20-07:00</lastmod></url><url><loc>https://www.sutrobio.com/associate-scientist-upstream-process-development-south-san-francisco/</loc><lastmod>2023-04-11T14:27:46-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-preclinical-data-for-its-ror1-targeting-antibody-drug-conjugate-stro-003-at-the-aacr-annual-meeting-2023/</loc><lastmod>2023-04-18T10:30:02-07:00</lastmod></url><url><loc>https://www.sutrobio.com/2023-american-association-for-cancer-research-annual-meeting-aacr-poster/</loc><lastmod>2024-04-14T12:54:04-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-the-departure-of-president-of-research-chief-scientific-officer/</loc><lastmod>2023-04-27T13:30:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-jmp-securities-life-sciences-conference-2/</loc><lastmod>2023-05-08T05:00:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-first-quarter-2023-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2023-05-15T05:00:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/2023-american-society-of-pediatric-hematology-oncology-aspho-annual-meeting-poster/</loc><lastmod>2024-04-14T12:44:22-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-the-jefferies-healthcare-conference/</loc><lastmod>2023-05-31T05:00:10-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-oral-presentation-at-asco-2023-featuring-data-for-luveltamab-tazevibulin-from-the-phase-1-dose-expansion-study-in-ovarian-cancer-and-the-initiation-of-the-phase-2-3-pivotal-s/</loc><lastmod>2023-06-03T13:17:26-07:00</lastmod></url><url><loc>https://www.sutrobio.com/2023-american-society-of-clinical-oncology-asco-annual-meeting-presentation/</loc><lastmod>2024-04-14T12:21:27-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-blackstone-announce-royalty-financing-collaboration/</loc><lastmod>2023-06-26T05:00:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-second-quarter-2023-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2023-08-10T13:30:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-upcoming-investor-conferences-4/</loc><lastmod>2023-08-30T05:00:05-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-dr-hans-peter-gerber-as-chief-scientific-officer/</loc><lastmod>2023-09-19T05:00:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-demonstrates-meaningful-adc-innovation-with-five-presentations-and-one-poster-at-the-14th-annual-world-adc-conference/</loc><lastmod>2023-10-16T13:05:02-07:00</lastmod></url><url><loc>https://www.sutrobio.com/14th-annual-world-adc-conference-presentations-and-poster/</loc><lastmod>2024-04-14T12:03:56-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-presentation-of-data-for-luveltamab-tazevibulin-luvelta-from-the-phase-1-dose-expansion-study-in-endometrial-cancers-at-esmo-2023/</loc><lastmod>2023-10-22T01:25:09-07:00</lastmod></url><url><loc>https://www.sutrobio.com/esmo-congress-2023-presentation/</loc><lastmod>2024-04-14T11:38:03-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-third-quarter-2023-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2023-11-13T13:30:06-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-promotes-jane-chung-to-president-and-chief-operating-officer/</loc><lastmod>2023-11-21T13:05:04-08:00</lastmod></url><url><loc>https://www.sutrobio.com/vaxcyte-exercises-option-and-enters-into-manufacturing-rights-agreement-with-sutro-biopharma-to-obtain-control-over-manufacturing-and-development-of-cell-free-extract-for-its-vaccine-candidates/</loc><lastmod>2023-11-27T13:05:02-08:00</lastmod></url><url><loc>https://www.sutrobio.com/piper-sandler-35th-annual-healthcare-conference-presentation/</loc><lastmod>2024-04-14T11:27:39-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-the-jmp-securities-hematology-and-oncology-summit/</loc><lastmod>2023-12-04T13:05:01-08:00</lastmod></url><url><loc>https://www.sutrobio.com/65th-american-society-of-hematology-annual-meeting-and-exposition-poster/</loc><lastmod>2024-02-11T18:26:18-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-new-positive-data-from-the-compassionate-use-of-luveltamab-tazevibulin-luvelta-in-pediatric-patients-with-relapsed-refractory-cbf-glis-presented-at-ash-2023/</loc><lastmod>2024-02-11T18:31:38-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-host-investor-webcast-highlighting-potential-multi-cancer-opportunity-for-luvelta-a-folr%ce%b1-targeted-adc-on-january-4-2024/</loc><lastmod>2024-02-11T18:38:02-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-highlights-potential-multi-cancer-opportunity-for-luvelta-a-folr%ce%b1-targeting-adc/</loc><lastmod>2024-02-11T18:43:18-08:00</lastmod></url><url><loc>https://www.sutrobio.com/luvelta-forum-presentation/</loc><lastmod>2024-02-11T19:25:12-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-participate-in-upcoming-investor-conferences-5/</loc><lastmod>2024-02-11T19:30:34-08:00</lastmod></url><url><loc>https://www.sutrobio.com/mabs-journal-production-of-antibodies-and-antibody-fragments-containing-non-natural-amino-acids-in-escherichia-coli/</loc><lastmod>2024-04-07T15:51:50-07:00</lastmod></url><url><loc>https://www.sutrobio.com/14th-annual-world-adc-london-2024-presentation/</loc><lastmod>2024-04-07T16:21:09-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-full-year-2023-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2024-04-07T16:34:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/ipsen-and-sutro-biopharma-announce-exclusive-global-licensing-agreement-for-an-adc-targeting-solid-tumors/</loc><lastmod>2024-04-07T16:42:02-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-pricing-of-75-million-underwritten-offering/</loc><lastmod>2024-04-07T16:45:54-07:00</lastmod></url><url><loc>https://www.sutrobio.com/bill-newell-ceo-interviewed-by-brad-loncar-founder-biotech-tv-sutro-biopharmas-ceo-on-adcs-non-cell-protein-synthesis-and-more/</loc><lastmod>2024-04-07T16:51:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-initiation-of-randomized-portion-part-2-of-refr%ce%b1me-o1-trial/</loc><lastmod>2024-04-30T05:00:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-first-quarter-2024-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2024-05-13T13:30:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-appoints-dr-barbara-leyman-as-chief-business-development-officer/</loc><lastmod>2024-07-09T05:02:43-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-second-quarter-2024-financial-results-business-highlights-and-select-anticipated-milestones/</loc><lastmod>2024-08-13T13:30:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-initiation-of-refr%ce%b1me-l1-phase-2-trial-with-luvelta-for-patients-with-non-small-cell-lung-cancer/</loc><lastmod>2024-08-22T05:00:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-host-research-forum-highlighting-next-generation-adc-innovation-and-near-term-pipeline-on-october-10-2024/</loc><lastmod>2024-09-11T05:00:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-updated-data-from-phase-1b-study-of-luvelta-in-combination-with-bevacizumab-at-esmo-2024/</loc><lastmod>2024-09-14T00:00:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/european-society-for-medical-oncology-esmo-congress-2024-poster/</loc><lastmod>2024-09-14T00:00:47-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-inducement-grant-under-nasdaq-listing-rule-5635c4/</loc><lastmod>2024-09-20T13:05:11-07:00</lastmod></url><url><loc>https://www.sutrobio.com/research-forum-presentation/</loc><lastmod>2024-11-20T07:37:50-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-highlights-next-generation-adc-innovation-and-near-term-pipeline-at-research-forum/</loc><lastmod>2024-10-10T13:05:04-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-initiation-of-the-registration-enabling-refr%ce%b1me-p1-trial-with-luvelta-for-pediatric-patients-with-cbf-glis-aml/</loc><lastmod>2024-11-01T05:00:07-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-demonstrates-meaningful-adc-innovation-with-five-presentations-at-the-15th-annual-world-adc-conference/</loc><lastmod>2024-11-04T13:05:10-08:00</lastmod></url><url><loc>https://www.sutrobio.com/15th-annual-world-adc-conference-presentations/</loc><lastmod>2024-11-07T16:50:18-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-third-quarter-2024-financial-results-and-business-highlights/</loc><lastmod>2024-11-13T13:30:11-08:00</lastmod></url><url><loc>https://www.sutrobio.com/jefferies-london-healthcare-conference-presentation-3/</loc><lastmod>2024-11-20T17:00:04-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-selected-dose-for-luvelta-and-topline-results-from-dose-optimization-portion-of-refr%ce%b1me-o1-trial-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2024-12-10T05:00:07-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-and-boehringer-ingelheim-bioxcellence-collaboration-established-first-in-class-cell-free-capabilities-at-commercial-scale/</loc><lastmod>2025-01-07T06:00:13-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-43rd-annual-j-p-morgan-healthcare-conference/</loc><lastmod>2025-01-07T13:05:06-08:00</lastmod></url><url><loc>https://www.sutrobio.com/43rd-annual-j-p-morgan-healthcare-conference-presentation/</loc><lastmod>2025-01-12T15:00:04-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-to-present-at-the-td-cowen-45th-annual-health-care-conference/</loc><lastmod>2025-03-03T13:05:02-08:00</lastmod></url><url><loc>https://www.sutrobio.com/15th-annual-world-adc-london-2025-presentation/</loc><lastmod>2025-03-04T01:30:02-08:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-announces-strategic-portfolio-review-resulting-in-the-prioritization-of-its-next-generation-adc-pipeline/</loc><lastmod>2025-03-13T13:05:06-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-reports-full-year-2024-financial-results-and-business-highlights/</loc><lastmod>2025-03-13T13:08:13-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-presents-data-from-dose-optimization-portion-of-refr%ce%b1me-o1-trial-in-patients-with-platinum-resistant-ovarian-cancer-at-sgo-2025/</loc><lastmod>2025-03-15T16:20:21-07:00</lastmod></url><url><loc>https://www.sutrobio.com/society-gynecologic-oncology-sgo-annual-meeting-on-womens-cancer-presentation/</loc><lastmod>2025-03-15T16:21:46-07:00</lastmod></url><url><loc>https://www.sutrobio.com/sutro-biopharma-inc-conference-call-presentation/</loc><lastmod>2025-03-15T08:31:24-07:00</lastmod></url></urlset>
